Here we find valuation comfort along with our desired growth rates. One sector where the exposure is negligible throughout has been IT and that remains the same as on today as well.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale